iiinova — where your digital self keeps evolving

Annique Claringbould @anniquec.bsky.social · 01/10/2026

Very happy that my grant proposal "From polygenic scores to regulatory profiles: Evaluating sequence-based AI in human β-cells" is funded by ZonMw's Off Road grant! 🎉 www.zonmw.nl/en/news/road... @erasmusmc.bsky.social

lnkd.in

This link will take you to a page that’s not on LinkedIn

130

Reposted by Annique Claringbould

Oded Rechavi @odedrechavi.bsky.social · 05/05/2026

I’m excited to announce that as of today we are officially releasing “QED for Grants” for everyone. What started off as an extension of our existing paper review platform, grew in the last few months to an entirely new design (2/16)

2143

Reposted by Annique Claringbould

Sasha Gusev @sashagusevposts.bsky.social · 01/04/2026

Here's a little widget to play with the data across journals (as well as download the raw CSVs). sashagusev.github.io/Genetics_Pub...

32913

Reposted by Annique Claringbould

Open Targets @opentargets.org · 12/03/2026

Out now on bioRxiv! 🧬🖥️ Dewi Moonen, @anniquec.bsky.social and a team led by Lars Steinmetz and Daniel Schraivogel at EMBL have mapped the downstream regulatory networks of thousands of immune disease-relevant variants in CD4+ T cells www.biorxiv.org/content/10.6...

biorxiv.org

1143

Reposted by Annique Claringbould

bioRxiv Genetics @biorxiv-genetic.bsky.social · 11/03/2026

Genome-scale mapping of variant, enhancer and gene function in primary human CD4+ T cells www.biorxiv.org/content/10.64898/20…

011

Annique Claringbould @anniquec.bsky.social · 12/03/2026

🧬 How do immune disease-relevant variants affect gene regulatory networks in CD4+ T cells? 🧪🖥️ We coupled two large-scale CRISPRi screens (>4M cells) to map the downstream cascades of thousands of SNPs More details in the thread below 👇 or in the article 📖 on biorxiv tinyurl.com/CD4screens

12811

Annique Claringbould @anniquec.bsky.social · 26/02/2026

Did you read our paper applying SUM-seq in macrophages, T-cells and iPSCs (www.nature.com/articles/s41...) and think: I want to try this cost-effective single cell RNA & ATAC-seq method myself? 🧬 Find the complete protocol including tips, troubleshooting and timing now in Nature Protocols

nature.com

Single-cell ultra-high-throughput multiplexed chromatin and RNA profiling reveals gene regulatory dynamics - Nature Methods

This work presents SUM-seq, an ultra-high-throughput method for co-profiling chromatin accessibility and gene expression in single nuclei across multiplexed samples, advancing the study of gene regula...

073

Reposted by Annique Claringbould

Danai Vagiaki @danaivagiaki.bsky.social · 08/02/2026

Delighted to present Latent Interaction Variational Inference (LIVI), a framework for trans-eQTL mapping at single-cell resolution that I developed during my PhD together with colleagues from @steglelab.bsky.social 1/n

12713

Annique Claringbould @anniquec.bsky.social · 11/02/2026

For anyone who asked "Do you have genome-wide trans-eQTLs?" when we published the first eQTLGen paper: we do now! 💫 See Robert's thread for details on eQTLGen phase 2, including finemapped cis-eQTLs, cis-trans gene pairs and integration of GWAS to identify trait-relevant pathways 🧬🖥 Congrats team!

091

Reposted by Annique Claringbould

Pieter T. L. Beck @ptrbck.bsky.social · 13/01/2026

The department of Philosophy and Moral Sciences at Ghent University is proud to present a lecture series on the topic of eugenics. As philosophers and ethicists, we are concerned about the revival and normalization of eugenic discourse. humanitiesacademie.ugent.be/eugenics

humanitiesacademie.ugent.be

Eugenics: Critical Perspectives on a Creeping Concept Between Science and Ideology | Humanities Academie

14925

Reposted by Annique Claringbould

Saloni @scientificdiscovery.dev · 09/12/2025

Big new blogpost! My guide to data visualization, which includes a very long table of contents, tons of charts, and more. --> Why data visualization matters and how to make charts more effective, clear, transparent, and sometimes, beautiful. www.scientificdiscovery.dev/p/salonis-gu...

28805313

Reposted by Annique Claringbould

Open Targets @opentargets.org · 18/09/2025

The Open Targets Platform autumn release is out! 🍂 We have ingested the full dataset of over 13 million enhancer-gene regulatory interactions in the human genome across 1,458 DNase-seq experiments covering 369 cell types and tissues from the ENCODE-rE2G model blog.opentargets.org/open-targets...

blog.opentargets.org

Open Targets Platform 25.09 has been released!

The September 25 release includes enhancer-gene data predicted by ENCODE-rE2G, molQTL credible sets for targets, new options for the variant structural viewer, and a number of data updates from GWAS C...

1229

Reposted by Annique Claringbould

Nicky Whiffin @nickywhiffin.bsky.social · 31/07/2025

📣 We are recruiting! Please share!! Are you a bioinformatician / computational scientist who wants to apply your skills to understanding regulatory biology and improving rare disease diagnosis and treatment? 🧠 💻 🧬 🩺 We have two roles available 👇 🧵 1/4

Image of an old building in Oxford with the heading 'postdoc opportunities' and the text 'computational approaches to improve rare disease diagnosis and treatment' and 'Big Data Institute, University of Oxford'

14443

Reposted by Annique Claringbould

Anthony Mathelier @amathelier.bsky.social · 24/07/2025

What a fantastic #ISMBECCB2025 conference it has been, with an outstanding #RegSys @iscb-regsys.bsky.social COSI track! Thanks, everyone, for submitting, attending, presenting, and organizing @iscb.bsky.social @eccb-europe.bsky.social

294

Reposted by Annique Claringbould

Anthony Mathelier @amathelier.bsky.social · 21/07/2025

The #RegSys @iscb-regsys.bsky.social track is gonna be outstanding again this year with a great selection of talks and keynotes @verapancaldi.bsky.social, Mafalda Dias, Roser Vento-Tormo, and @lucapinello.bsky.social ! www.iscb.org/ismbeccb2025...

iscb.org

RegSys

ISCB - International Society for Computational Biology

064

Reposted by Annique Claringbould

Žiga Avsec @avsecz.bsky.social · 25/06/2025

Excited to launch our AlphaGenome API goo.gle/3ZPUeFX along with the preprint goo.gle/45AkUyc describing and evaluating our latest DNA sequence model powering the API. Looking forward to seeing how scientists use it! @googledeepmind

521982

Annique Claringbould @anniquec.bsky.social · 19/06/2025

How do schizophrenia-linked transcription factors and chromatin regulators affect gene regulation in neurons? 🧬🧠 We assess the functional consequences of ❌knocking down❌ 65 SCZ genes and find that they disrupt neurodevelopmental timing ➡️🕐 See paper for GRNs 🖥️, validation screens ✅ & mechanisms 🧩

0112

Reposted by Annique Claringbould

Axel Visel @axelvisel.bsky.social · 18/06/2025

Textbooks: “Enhancers are just a bunch of TFBSs” But how do they REALLY work? New paper with many contributors here @berkeleylab.lbl.gov, @anshulkundaje.bsky.social, @anusri.bsky.social A 🧵 (1/n) Free access link: rdcu.be/erD22

A meme-style comic panel with three parts. Left: A stylized enhancer with a mutation, surrounded by colored blocks representing functional motifs, a neural network diagram, chromatin accessibility signal traces, and a sequence motif. Two cartoon mouse embryos below show different LacZ reporter activity patterns. Top right: A hand hovers anxiously between two red buttons labeled “Experiments” and “AI,” with the caption “HOW DO ENHANCERS REALLY WORK?” Bottom right: A sweating superhero wipes his forehead, looking stressed about the difficult choice.

216479

Reposted by Annique Claringbould

Simon Fisher @profsimonfisher.bsky.social · 14/06/2025

Your genome is not a blueprint. A thread about misleading metaphors in science communication. 🧬🧪 1/n

919866

Reposted by Annique Claringbould

Nature Methods @natmethods.nature.com · 27/05/2025

SUM-seq is an ultra-high-throughput method for co-profiling chromatin accessibility and gene expression in single nuclei. @anniquec.bsky.social www.nature.com/articles/s41...

1134

Annique Claringbould @anniquec.bsky.social · 27/05/2025

Justified standing ovation for Nobel laureate Katalin Karikó at #ESHG2025 She shared her adventurous scientific life and life lessons like "If you want to do something, you find a way. If not, you find excuses", and reminded us scientists to thank our near and dear because "they suffer a little bit"

0438

Reposted by Annique Claringbould

Mikael Marttinen @mmarttinen.bsky.social · 26/05/2025

This was a long, fun project, which took the effort of many talented people (Sara Lobato, Umut Yildiz, @anniquec.bsky.social et al.) from the Zaugg and Noh labs! @embl.org @unibas.ch A detailed protocol is in the works for release. For now, check out the paper!

021

Annique Claringbould @anniquec.bsky.social · 26/05/2025

SUM-seq is now out 🤩 See Mikael's thread below for paper highlights

0112

Reposted by Annique Claringbould

Luke Jostins-Dean @lukejostins.bsky.social · 26/05/2025

Annique Claringbould @anniquec.bsky.social is talking about CRISPR interference in primary CD4 T cells for ~1000 GWAS-implicated enhancers, reading out ~2000 genes. Interfering with some key enhancers (CD28, IL2RA) impact basically every CD4-expressed gene. #eshg2025

122

Annique Claringbould @anniquec.bsky.social · 26/05/2025

Today I'm presenting some unpublished work of a CRISPRi screen targeting T-cell-specific enhancers that overlap immune disease GWAS hits in session S14 at #ESHG2025 - hope to see you there!

070

Annique Claringbould @anniquec.bsky.social · 24/05/2025

Ciao Milano! Looking forward to #eshg2025 these next days

0120

Annique Claringbould @anniquec.bsky.social · 12/05/2025

Wonderful resource if you're looking to catch up on sequence language models in genomics!

031

Reposted by Annique Claringbould

European Commission @ec.europa.eu · 08/05/2025

Choose Science. Choose Europe. A new Marie Skłodowska-Curie Actions Postdoctoral Fellowships 2025 call is now open. With a budget of €404.3 million, it will support around 1,650 researchers from Europe and beyond. Apply by 10 September → europa.eu/!fBTMgF

15948556

Reposted by Annique Claringbould

Tuuli Lappalainen @tuuliel.bsky.social · 06/05/2025

Our new contribution to the quest to find causal GWAS genes! Sam Ghatan from my lab at @nygenome.org led a systematic comparison of eQTLs and CRISPRi+scRNA-seq screens. TL;DR: they provide highly complementary insights, with ortogonal pros and cons. 🧵👇 www.biorxiv.org/content/10.1...

19842

Reposted by Annique Claringbould

Mike Inouye @mikeinouye.bsky.social · 08/04/2025

📣📣 New postdoc in biomedical data science available in our lab!! www.jobs.cam.ac.uk/job/50966/ Flexible funding - many research areas in scope + ideas welcome Check out our group www.inouyelab.org/home And the awesome Cambridge research environment! @vpd-hlri.bsky.social @uniofcam.bsky.social

02422

Reposted by Annique Claringbould

Jelle Slager @jslager.bsky.social · 04/04/2025

Just out! Our manuscript (led by Pauline Lanting and @robertwarmerdam.bsky.social) on the generation of pharmacogenetic passports from low-cost GSA oligonucleotide array data.

074

Annique Claringbould @anniquec.bsky.social · 04/04/2025

I want to share some observations from a recent recruitment process for a PhD position that may be interesting for other future candidates 🧵

271

Reposted by Annique Claringbould

Abdel Abdellaoui @dr-appie.bsky.social · 26/03/2025

In every civilization, people end up sorted into levels of socio-economic status (SES). We explore the history, present, and future of scientific research on the complicated relationship between SES and DNA in @naturehumbehav.bsky.social💰🧬🎓 Link: rdcu.be/efacK Thread below 👇🏽

623383

Annique Claringbould @anniquec.bsky.social · 07/03/2025

Exciting day! It's the opening of the Netherlands Women's Health Research and Innovation Center @erasmusmc.bsky.social

040

Reposted by Annique Claringbould

Mike Inouye @mikeinouye.bsky.social · 04/03/2025

📣 New from the lab: The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes www.nature.com/articles/s41... Check out the INTERVAL RNAseq portal www.intervalrna.org.uk Led by @alextokolyi.bsky.social & Elodie Persyn!

03918

Reposted by Annique Claringbould

EMBL @embl.org · 27/01/2025

Recruitment for the EMBL International PhD Programme is officially open! 🔊 At EMBL, we train young scientists to become skilled and creative future leaders in academia, industry & other sectors. Start your career in the life sciences with us! www.embl.org/about/info/e... 🧪 #AcademicSky #careers

EMBL International PhD Programme Summer Recruitment Applications open. Applications close 10 March 2025.

02916

Annique Claringbould @anniquec.bsky.social · 09/01/2025

Come do a PhD with me! 🖥️🧬 We've got very exciting multiomics data coming in, you get to shape the project and there are lots of opportunities to collaborate and learn. Reach out here or via email if you have questions Please reskeet 🙏 www.werkenbijerasmusmc.nl/en/vacancy/1...

werkenbijerasmusmc.nl

Vacature: PhD candidate in gene regulatory mechanisms underpinning cardiovascular diseases

We are seeking a motivated PhD student to join our lab at Erasmus University Medical Centre in Rotterdam, exploring the gene regulatory mechanisms underpinning cardiovascular diseases. Type 2 diabetes...

0114

Reposted by Annique Claringbould

Saez-Rodriguez Group @saezlab.bsky.social · 23/12/2024

We present Gene Regulatory nETwork Analsyis (GRETA), a framework to infer, compare and evaluate gene regulatory networks #GRNs. With it, we have benchmarked multimodal and unimodal GRN inference methods. Check the results here 👇 Paper: doi.org/10.1101/2024.12.20.629764 Code: github.com/saezlab/greta

112746

Reposted by Annique Claringbould

Tuuli Lappalainen @tuuliel.bsky.social · 18/12/2024

🌟 Exciting news: The Leena Peltonen School of Human Genetics returns in 2025! We're excited to bring PhD students together with an all-star list of leaders in human genetics. 📅 July 27-31, 2025 📍 Wellcome Genome Campus, UK 📝 Apply by March 7 at www.lpshg.com

14828

Reposted by Annique Claringbould

David Ochoa @d0choa.bsky.social · 17/12/2024

From next spring, the Open Targets Platform will incorporate the best of Open Targets Genetics into an integrated drug discovery platform 🧵

2187

Reposted by Annique Claringbould

Joram Mooiweer @jorammooiweer.bsky.social · 10/12/2024

From GWAS variants⚡️to key-genes🧬: Downstreamer is your tool! This tool developed by (former) colleagues @patrickdeelen.bsky.social, @anniquec.bsky.social and Olivier Bakker incorporates GWAS Variants and tissue specific co-regulation to identify key genes for common diseases 👇Explainer

051

Annique Claringbould @anniquec.bsky.social · 05/12/2024

Proud to share my final PhD work! 🧬🖥️ This article is about finding KEY DISEASE GENES using GWAS and gene expression patterns, nicely explained in Patrick's thread below. But it's also a story about perseverence and team work across institutions, thanks to Olivier, Lude and Patrick 🙏

0160

Reposted by Annique Claringbould

Leopold Parts @leopoldparts.bsky.social · 02/12/2024

Does my mutation have the same impact as yours? Population genetics 🤠 🥸 🤓 🤡 meets single cell CRISPRi ⚡ ! www.biorxiv.org/content/10.1... Led by Claudia Feng, Oliver Stegle, Britta Velten, @sangerinstitute.bsky.social .

lnkd.in

This link will take you to a page that’s not on LinkedIn

25824

Reposted by Annique Claringbould

Michel Nivard @michelnivard.bsky.social · 28/11/2024

🚨 This will become a curated list of awesome tools for complex trait genetics, **add yours**! it may become a review in which case those who contribute are invited as co-authors.

github.com

GitHub - MichelNivard/awesome-complex-trait-genetics: A list of awesome tools for complex trait genetics.

A list of awesome tools for complex trait genetics. - MichelNivard/awesome-complex-trait-genetics

78243